Neanderthal-derived protein may reduce the severity of COVID-19
A missing protein promotes genetic instability in patients with Mulibrey syndrome
26 February 2021Decline in U.S. suicide rates from 2018 to 2019 not uniform
26 February 2021Neanderthal-derived protein may reduce the severity of COVID-19
Researchers at the Lady Davis Institute (LDI) at the Jewish General Hospital have discovered that increased levels of the protein OAS1 are associated with reduced mortality and less severe disease requiring ventilation among patients with COVID-19. Using drugs that boost OAS1 levels could be explored to try to improve these outcomes. The findings are published today in Nature Medicine.
